Zhejiang Kanova Biopharmaceutical Co., Ltd
Clinical trials sponsored by Zhejiang Kanova Biopharmaceutical Co., Ltd, explained in plain language.
-
New injection aims to improve breathing in COPD patients
Disease control Not yet recruitingThis study tests an experimental drug called XKH001 in 75 people with moderate to severe COPD. The drug is given as an injection to see if it can improve lung function and reduce symptoms over 24 to 48 weeks. Participants are randomly assigned to receive either the drug or a plac…
Phase: PHASE2 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a new antibody tame the Body's allergic alarm system?
Knowledge-focused Not yet recruitingThis early-stage trial is testing an experimental drug called XKH001 in healthy Caucasian adults. The drug is an antibody designed to block a protein involved in allergic and inflammatory responses. The study aims to see how the body processes the drug, whether it is safe and wel…
Phase: PHASE1 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC